| 1 |
Brenner H, Kloor M, Pox CP. Colorectal cancer[J]. Lancet, 2014, 383(9927):1490-1502.
|
| 2 |
van der Geest LG, Lam-Boer J, Koopman M, et al. Nationwide trends in incidence, treatment and survival of colorectal cancer patients with synchronous metastases[J]. Clin Exp Metastasis, 2015, 32(5):457-465.
|
| 3 |
van der Geest LG, Lam-Boer J, Koopman M, et al. Nationwide trends in incidence, treatment and survival of colorectal cancer patients with synchronous metastases[J]. Clin Exp Metastasis, 2015, 32(5):457-465.
|
| 4 |
Holch JW, Demmer M, Lamersdorf C, et al. Pattern and dynamics of distant metastases in metastatic colorectal cancer[J]. Visc Med, 2017, 33(1):70-75.
|
| 5 |
Simmonds PC. Palliative chemotherapy for advanced colorectal cancer：systematic review and meta-analysis. Colorectal Cancer Collaborative Group[J] BMJ, 2000, 321(7260):531-535.
|
| 6 |
Robinson JR, Newcomb PA, Hardikar S, et al. Stage Ⅳ colorectal cancer primary site and patterns of distant metastasis[J]. Cancer Epidemiol, 2017, 48:92-95.
|
| 7 |
国家卫生计生委医政医管局、中华医学会肿瘤学分会. 中国结直肠癌诊疗规范(2017年版)[J]. 中华胃肠外科杂志，2018, 21(1):92-106.
|
| 8 |
Prasanna T, Karapetis CS, Roder D, et al. The survival outcome of patients with metastatic colorectal cancer based on the site of metastases and the impact of molecular markers and site of primary cancer on metastatic pattern[J]. Acta Oncol, 2018, 57(11):438-1444.
|
| 9 |
Vatandoust S, Price TJ, Karapetis CS. Colorectal cancer: metastases to a single organ[J]. World J Gastroenterol, 2015, 21(41):11767-11776.
|
| 10 |
Rahbari NN, Carr PR, Jansen L, et al. Time of metastasis and outcome in colorectal cancer[J]. Ann Surg, 2019, 269(3):494-502.
|
| 11 |
Shimura T, Toiyama Y, Saigusa S, et al. Inflammation based prognostic scores as indicators to select candidates for primary site resection followed by multimodal therapy among colorectal cancer patients with multiple metastases[J]. Int J Clin Oncol, 2017, 22(4):758-766.
|
| 12 |
McMillan DC. The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer[J]. Cancer Treat Rev, 2013, 39(5):534-540.
|
| 13 |
Kriegsmann M, Harms A, Longuespée R, et al. Role of conventional immunomarkers, HNF4-α and SATB2, in the differential diagnosis of pulmonary and colorectal adenocarcinomas[J]. Histopathology, 2018, 72(6):997-1006.
|
| 14 |
Kim JH, Kang GH. Molecular and prognostic heterogeneity of microsatellite-unstable colorectal cancer[J]. World J. Gastroenterol, 2014, 20(15):4230-4243.
|
| 15 |
Su X, Xue Y, Wei J, et al. Establishment and characterization of gc-006-03, a Novel Human signet ring cell gastric cancer cell line derived from metastatic ascites[J]. J Cancer, 2018, 9(18):3236-3246.
|
| 16 |
Kuroda N, Yorita K. Colon cancer with micropapillary carcinoma component：a clinopathologic study of 9 cases[J]. Pol J Pathol, 2017, 68(2):102-108.
|
| 17 |
Bian T, Zhao J, Feng J, et al. Combination of cadherin-17 and SATB homeobox 2 serves as potential optimal makers for the differential diagnosis of pulmonary enteric adenocarcinoma and metastatic colorectal adenocarcinoma[J]. Oncotarget, 2017, 8(38):63442-63452.
|